Literature DB >> 17584898

Transglutaminase crosslinked gelatin as a tissue engineering scaffold.

C W Yung1, L Q Wu2,3, J A Tullman1, G F Payne2,3, W E Bentley1,2, T A Barbari1.   

Abstract

Gelatin is one of the most commonly used biomaterials for creating cellular scaffolds due to its innocuous nature. In order to create stable gelatin hydrogels at physiological temperatures (37 degrees C), chemical crosslinking agents such as glutaraldehyde are typically used. To circumvent potential problems with residual amounts of these crosslinkers in vivo and create scaffolds that are both physiologically robust and biocompatible, a microbial transglutaminase (mTG) was used in this study to enzymatically crosslink gelatin solutions. HEK293 cells encapsulated in mTG-crosslinked gelatin proliferated at a rate of 0.03 day(-1). When released via proteolytic degradation with trypsin, the cells were able to recolonize tissue culture flasks, suggesting that cells for therapeutic purposes could be delivered in vivo using an mTG-crosslinked gelatin construct. Upon submersion in a saline solution at 37 degrees C, the mTG-crosslinked gelatin exhibited no mass loss, within experimental error, indicating that the material is thermally stable. The proteolytic degradation rate of mTG-crosslinked gelatin at RT was slightly faster than that of thermally-cooled (physically-crosslinked) gelatin. Thermally-cooled gelatin that was subsequently crosslinked with mTG resulted in hydrogels that were more resistant to proteolysis. Degradation rates were found to be tunable with gelatin content, an attribute that may be useful for either long-time cell encapsulation or time-released regenerative cell delivery. Further investigation showed that proteolytic degradation was controlled by surface erosion. (c) 2007 Wiley Periodicals, Inc. J Biomed Mater Res, 2007.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17584898     DOI: 10.1002/jbm.a.31431

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  47 in total

1.  Crosslinking of gelatin-based drug carriers by genipin induces changes in drug kinetic profiles in vitro.

Authors:  Goutam Thakur; Analava Mitra; Dérick Rousseau; Amit Basak; Siddik Sarkar; Kunal Pal
Journal:  J Mater Sci Mater Med       Date:  2010-11-25       Impact factor: 3.896

2.  Designer Hydrogels for Precision Control of Oxygen Tension and Mechanical Properties.

Authors:  Michael Blatchley; Kyung Min Park; Sharon Gerecht
Journal:  J Mater Chem B       Date:  2015-08-05       Impact factor: 6.331

3.  Injectable Macroporous Hydrogel Formed by Enzymatic Cross-Linking of Gelatin Microgels.

Authors:  Shujie Hou; Rachel Lake; Shiwha Park; Seth Edwards; Chante Jones; Kyung Jae Jeong
Journal:  ACS Appl Bio Mater       Date:  2018-10-15

4.  A multi-interpenetrating network (IPN) hydrogel with gelatin and silk fibroin.

Authors:  Shiwha Park; Seth Edwards; Shujie Hou; Ryann Boudreau; Rachel Yee; Kyung Jae Jeong
Journal:  Biomater Sci       Date:  2019-03-26       Impact factor: 6.843

5.  Improving the stability of chitosan-gelatin-based hydrogels for cell delivery using transglutaminase and controlled release of doxycycline.

Authors:  Christian J Tormos; Carol Abraham; Sundararajan V Madihally
Journal:  Drug Deliv Transl Res       Date:  2015-12       Impact factor: 4.617

6.  O2-controllable hydrogels for studying cellular responses to hypoxic gradients in three dimensions in vitro and in vivo.

Authors:  Daniel M Lewis; Michael R Blatchley; Kyung Min Park; Sharon Gerecht
Journal:  Nat Protoc       Date:  2017-07-20       Impact factor: 13.491

Review 7.  Engineering cardiac microphysiological systems to model pathological extracellular matrix remodeling.

Authors:  Nethika R Ariyasinghe; Davi M Lyra-Leite; Megan L McCain
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-15       Impact factor: 4.733

8.  Modulating In Vivo Degradation Rate of Injectable Extracellular Matrix Hydrogels.

Authors:  Jean W Wassenaar; Rebecca L Braden; Kent G Osborn; Karen L Christman
Journal:  J Mater Chem B       Date:  2016-03-28       Impact factor: 6.331

9.  Tumor-derived endothelial cells exhibit aberrant Rho-mediated mechanosensing and abnormal angiogenesis in vitro.

Authors:  Kaustabh Ghosh; Charles K Thodeti; Andrew C Dudley; Akiko Mammoto; Michael Klagsbrun; Donald E Ingber
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-06       Impact factor: 11.205

10.  Click-Crosslinked Injectable Gelatin Hydrogels.

Authors:  Sandeep T Koshy; Rajiv M Desai; Pascal Joly; Jianyu Li; Rishi K Bagrodia; Sarah A Lewin; Neel S Joshi; David J Mooney
Journal:  Adv Healthc Mater       Date:  2016-01-25       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.